What does SymBiosis Capital Partners, LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

SymBiosis Capital Partners, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

Evommune, Inc.

$29M1.3M55.8%

Inventiva S.A.

$13M2.4M24.8%

Wave Life Sciences Ltd.

$5M750K10.3%

Rani Therapeutics Holdings, Inc.

$3M3.7M5.1%

Clene Nanomedicine Inc.

$2M431K4.0%

Surrozen, Inc.

$2,400150K0.0%

Filing history loading…